 SOUTH SAN FRANCISCO, Calif., Oct. 01, 2021 GLOBE NEWSWIRE -- Cytokinetics, Incorporated Nasdaq: CYTK today announced that on September 30, 2021 it granted stock options to purchase an aggregate of 206,300 shares of common stock to 14 new employees, whose employment commenced in September 2021, as a material inducement to their employment. 